Clip | Code No. | Product | Data | ||||
---|---|---|---|---|---|---|---|
Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
Sequence | Location (aa) | Storage
temp. |
|||||
|
|||||||
TB-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
||||||
cancer | APC | A*01:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
KSDICTDEY | 243-251 | 4°C | |||||
TB-0119-1 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-PE |
||||||
cancer | PE | B*07:02 | 50 tests | ¥190,000 |
0 (Contact us) |
||
LPWHRLFLL | 208-216 | 4°C | |||||
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
||
SLLPAIVEL | 402-410 | 4°C | |||||
TB-M120-1 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
FLTPKKLQCV | 141-150 | 4°C | |||||
TB-M075-2 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
KVAELVHFL | 112-120 | 4°C | |||||
TB-5115-4 |
H-2Db Copine-1 Neoepitope Tetramer-SSPYSLHYL-BV421 |
||||||
cancer | BV421 | H-2Db | 50 tests | ¥190,000 |
0 (Contact us) |
||
SSPYSLHYL | 4°C | ||||||
TB-5104-1 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-PE |
||||||
cancer | PE | H-2Kd | 50 tests | ¥190,000 |
0 (Contact us) |
||
SYMLQALCI | 4°C | ||||||
TB-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YLEPGPVTV | 4°C | ||||||
TB-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YLQVNSLQTV | 4°C | ||||||
TB-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
VLPLTVAEV | 4°C | ||||||
TB-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
VLPLTVAEV | 4°C | ||||||
TB-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
VLPLTVAEV | 4°C | ||||||
TB-0013-4 |
T-Select HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
IMDQVPFSV | 209-217 | 4°C | |||||
TB-5108-4 |
H-2Db Survivin Tetramer-ATFKNWPFL-BV421 |
||||||
cancer | BV421 | H-2Db | 50 tests | ¥190,000 |
0 (Contact us) |
||
ATFKNWPFL | 20-28 | 4°C | |||||
TB-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
QLCPICRAPV | 175-184 | 4°C | |||||
TB-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
QLCPICRAPV | 175-184 | 4°C | |||||
TB-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
AILALLPAL | 105-133 | 4°C | |||||
TB-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
||||||
cancer | BV421 | A*01:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
KSDICTDEY | 243-251 | 4°C | |||||
TS-M078-2 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
||
GLYDGMEHL | 254-262 | 4°C | |||||
TS-M083-2 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
||
KLQDASAEV | 126-134 | 4°C | |||||
TS-M084-1 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
||
TLADFDPRV | 883-891 | 4°C | |||||
TB-0013-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (IMDQVPFSV) |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
IMDQVPFSV | 209-217 | 4°C | |||||
TB-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YLEPGPVTA | 280-288 | 4°C | |||||
TB-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
||||||
cancer | BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
ALLAVGATK | 4°C | ||||||
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
QLCPICRAPV | 175-184 | 4°C | |||||
TB-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
KLCPVQLWV | 139-147 | 4°C | |||||
TB-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
KLCPVQLWV | 139-147 | 4°C | |||||
TB-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GLLGASVLGL | 674-683 | 4°C | |||||
TB-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GLAPPQHLIRV | 187-197 | 4°C | |||||
TB-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
FLYDDNQRV | 828-836 | 4°C | |||||
TB-0119-2 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-APC |
||||||
cancer | APC | B*07:02 | 50 tests | ¥190,000 |
0 (Contact us) |
||
LPWHRLFLL | 208-216 | 4°C | |||||
TS-M071-2 |
HLA-B*07:02 MAGE-A1 Tetramer-RVRFFFPSL-APC |
||||||
cancer | APC | B*07:02 | 50 tests | ¥209,000 | 1-9 | ||
RVRFFFPSL | 289-297 | 4°C | |||||
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TS-M081-2 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
||
LLGRNSFEV | 264-272 | 4°C | |||||
TS-M084-2 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
||
TLADFDPRV | 883-891 | 4°C | |||||
TB-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
SLLFLLFSL | 4°C | ||||||
TB-0017-2 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
VLQELNVTV | 169-177 | 4°C | |||||
TB-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TB-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
SLPPPGTRV | 149-157 | 4°C | |||||
TB-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GLLGASVLGL | 674-683 | 4°C | |||||
TB-0129-4 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-BV421 |
||||||
cancer | BV421 | B*35:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
MPFATPMEA | 94-102 | 4°C | |||||
TB-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TB-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YMCSFLFNL | 666-674 | 4°C | |||||
TB-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TB-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
SLPPPGTRV | 149-157 | 4°C | |||||
TB-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GLQHWVPEL | 97-106 | 4°C | |||||
TB-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GLAPPQHLIRV | 187-197 | 4°C | |||||
TB-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TB-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TB-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GLLGASVLGL | 674-683 | 4°C | |||||
TB-0169-2 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | |||||
TB-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | |||||
TB-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YMCSFLFNL | 666-674 | 4°C | |||||
TB-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
KLCPVQLWV | 139-147 | 4°C | |||||
TB-0134-1 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (Contact us) |
||
FVGEFFTDV | 144-152 | 4°C |